biostudies-literatureUnknown10(7)Maltoni RAnnals of translational medicine389https://www.ebi.ac.uk/biostudies/studies/S-EPMC9073799biostudies-literatureSacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer.PMC9073799Bravaccini SMaltoni RfalseSacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer.2022-01-01T00:00:00Z2022 Apr2025-04-27T03:16:11.215Z2025-04-06T18:45:46.871ZS-EPMC90737993553093610.21037/atm-21-6999